The company is a high-tech enterprise with core technology for peptide synthesis and modification. It has advanced and efficient peptide drug process development and large-scale production capabilities. The company's main business is to independently develop, produce and sell peptide raw materials and formulation products with large market capacity and strong competitiveness at home and abroad. At the same time, the company relies on its technical advantages in the field of peptide drug development and large-scale production to provide pharmaceutical research services for innovative peptide drugs, customized production services for peptide products, and technology transfer services for peptide drug production to domestic and foreign pharmaceutical companies. In addition, the company also provides proxy processing of small molecule chemical levosimendan preparations and production, export and sales of levosimendan APIs. The company is committed to providing pharmaceutical research and customized production services for research and development of innovative peptides for domestic and foreign pharmaceutical companies, and independently develops, produces and sells polypeptide generic drug raw materials and formulation products, and peptide drug production technology transfer services. The company's main products and services: CDMO services for innovative peptide drugs, peptide raw materials and formulation products, customized production services for peptide products, and peptide drug production technology transfer services. Corporate honors: Outstanding Trade Union Work Unit in 2015, Chengdu Enterprise Technology Center in 2016, etc.
See the daily top gainer.